1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
Exelixis Inc XNAS: EXEL

Exelixis Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

Read More
44.04 -0.11 (-0.25%)
38.06% Gain from 52W Low
2.8M
XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Exelixis Inc is scheduled for today, for the purpose of J.P. Morgan 2026 Healthcare Conference See details
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Mid Valuation
45.7 / 100
Momentum Score
Technically Neutral
56.8 / 100
Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM
Analyst Price Target
46
1Yr Price target upside is 3%
18 analysts

20

S

6

W

5

O

0

T

SWOT Analysis

Exelixis Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..